Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
A

ABBV

NYSE

AbbVie Inc.

Latest disclosureOctober 2, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 1 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 21

Limited filing history
All21Buying0Selling1Other20
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

21 trades · March 31, 2026 – September 30, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Award disclosed

Susan E. Quaggin

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context
$15.43K
Reported price
$261.59 / derivative unit
Traded September 30, 2026Filed October 2, 2026SEC filing
Award disclosed

Edward J. Rapp

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context
$33.75K
Reported price
$261.59 / derivative unit
Traded September 30, 2026Filed October 2, 2026SEC filing
Exercise or conversion

Nicholas Donoghoe

EVP, CHIEF BUS/STRAT OFFICER

Common Stock, $0.01 par value

Value context
$2.58M
Reported price
$79.02 / share
Traded August 14, 2026Filed August 18, 2026SEC filing
Sale disclosed

Nicholas Donoghoe

EVP, CHIEF BUS/STRAT OFFICER

Common Stock, $0.01 par value

Reported value
$8.18M
Reported price
$250.00 / share
Traded August 14, 2026Filed August 18, 2026SEC filing
Exercise or conversion

Nicholas Donoghoe

EVP, CHIEF BUS/STRAT OFFICER

Option (Right to buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$79.02 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 14, 2026Filed August 18, 2026SEC filing
Award disclosed

Edward J. Rapp

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context
$33.72K
Reported price
$251.64 / derivative unit
Traded June 30, 2026Filed July 2, 2026SEC filing
Award disclosed

Susan E. Quaggin

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context
$15.6K
Reported price
$251.64 / derivative unit
Traded June 30, 2026Filed July 2, 2026SEC filing
Award disclosed

Thomas J. Falk

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Frederick H. Waddell

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Rebecca B. Roberts

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Edward J. Rapp

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Susan E. Quaggin

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Melody B. Meyer

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Brett J. Hart

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Thomas C. Freyman

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Jennifer L. Davis

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

William H.L. Burnside

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Roxanne S. Austin

Director

Common Stock, $0.01 par value

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded May 8, 2026Filed May 12, 2026SEC filing
Award disclosed

Susan E. Quaggin

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context
$15.44K
Reported price
$217.49 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Award disclosed

Edward J. Rapp

Director

Stock Equivalent Units

Derivative security · not the ordinary share price.

Value context
$33.71K
Reported price
$217.49 / derivative unit
Traded March 31, 2026Filed April 2, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorStock Equivalent UnitsGrant or awardDerivative units59$261.59 / derivative unit$15.43KSep 30Filed Oct 2 · 2d laterSEC filing
DirectorStock Equivalent UnitsGrant or awardDerivative units129$261.59 / derivative unit$33.75KSep 30Filed Oct 2 · 2d laterSEC filing
EVP, CHIEF BUS/STRAT OFFICERCommon Stock, $0.01 par valueOption exercise or conversion32,710$79.02 / share$2.58MAug 14Filed Aug 18 · 4d laterSEC filing
EVP, CHIEF BUS/STRAT OFFICERCommon Stock, $0.01 par valueSale32,710$250.00 / share$8.18MAug 14Filed Aug 18 · 4d laterSEC filing
EVP, CHIEF BUS/STRAT OFFICEROption (Right to buy)Option exercise or conversionDerivative units32,710$79.02 exercise / conversion priceNot a separate purchaseAug 14Filed Aug 18 · 4d laterSEC filing
DirectorStock Equivalent UnitsGrant or awardDerivative units134$251.64 / derivative unit$33.72KJun 30Filed Jul 2 · 2d laterSEC filing
DirectorStock Equivalent UnitsGrant or awardDerivative units62$251.64 / derivative unit$15.6KJun 30Filed Jul 2 · 2d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorCommon Stock, $0.01 par valueGrant or award1,118Award · no purchase priceNon-cash awardMay 8Filed May 12 · 4d laterSEC filing
DirectorStock Equivalent UnitsGrant or awardDerivative units71$217.49 / derivative unit$15.44KMar 31Filed Apr 2 · 2d laterSEC filing
DirectorStock Equivalent UnitsGrant or awardDerivative units155$217.49 / derivative unit$33.71KMar 31Filed Apr 2 · 2d laterSEC filing

Showing the latest 20 of 21 trades. Show all 21 trades

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001551152
Latest public acceptance
Oct 2, 2026, 09:00 PM UTC
Score calculated
Oct 7, 2026, 12:08 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Congress transactions 12

All Congress filings
Sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a sale for the member.

Pete Sessions official portraitPete SessionsReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
September 14, 2026
Filed September 18, 2026 · 4d laterOriginal report
Purchase disclosed

AbbVie Inc. Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
March 27, 2026
Filed July 21, 2026 · 116d laterOriginal report
Sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a sale for a joint account.

Josh Gottheimer official portraitJosh GottheimerReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
May 5, 2026
Filed June 3, 2026 · 29d laterOriginal report
Sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
December 18, 2025
Filed January 15, 2026 · 28d laterOriginal report
Sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a sale for the member.

Julia Letlow official portraitJulia LetlowReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
December 8, 2025
Filed January 13, 2026 · 36d laterOriginal report
Purchase disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a purchase for the member.

Julia Letlow official portraitJulia LetlowReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
April 28, 2025
Filed January 13, 2026 · 260d laterOriginal report
Sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a sale for the member.

Julia Letlow official portraitJulia LetlowReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
January 24, 2025
Filed January 13, 2026 · 354d laterOriginal report
Purchase disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a purchase for the member.

Julia Letlow official portraitJulia LetlowReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 23, 2024
Filed January 13, 2026 · 447d laterOriginal report
Partial sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a partial sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 13, 2025
Filed December 11, 2025 · 28d laterOriginal report
Sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 31, 2025
Filed November 21, 2025 · 21d laterOriginal report
Purchase disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a purchase for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 30, 2025
Filed November 21, 2025 · 22d laterOriginal report
Sale disclosed

AbbVie Inc. Common Stock (ABBV) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 30, 2025
Filed November 21, 2025 · 22d laterOriginal report